Insider Transactions in Q4 2021 at Equillium, Inc. (EQ)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2021
|
Joel Rothman Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,290
+5.04%
|
$2,580
$2.35 P/Share
|
|
Dec 10
2021
|
Jason A Keyes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,585
+19.34%
|
$11,170
$2.35 P/Share
|
|
Dec 01
2021
|
Jason A Keyes Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
5,000
-4.87%
|
$25,000
$5.08 P/Share
|
|
Nov 16
2021
|
Christine Zedelmayer Sr. Vice President and COO |
SELL
Open market or private sale
|
Direct |
11,434
-5.41%
|
$57,170
$5.49 P/Share
|
|
Nov 16
2021
|
Christine Zedelmayer Sr. Vice President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,334
+9.9%
|
$46,668
$2.45 P/Share
|
|
Oct 06
2021
|
Stephen Connelly Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,092
-0.41%
|
$56,644
$7.01 P/Share
|
|
Oct 06
2021
|
Stephen Connelly Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,092
+0.4%
|
$24,276
$3.78 P/Share
|